4007787550
| Cas号 | 结构式 | 品名 | 分子式 | 分子量 |
| 3800-06-4 |  |
2-氨基-4'-氟二苯甲酮 2-Amino-4'-fluorobenzophenone |
C13H10FNO | 215.22 |
| 287714-41-4 | |
7-[4-(4-氟苯基)-6-异丙基-2-(甲基-甲磺酰-氨基)-嘧啶-5-基]-3,5-二羟基庚-6-烯酸 Rosuvastatin |
C22H24D3FN3NaO6S | 481.54 |
| 355806-00-7 | |
(6E)-7-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰氨基)嘧啶-5-基]-(3R,5S)-3,5-二羟基庚-6-烯酸叔丁酯 |
C26H36FN3O6S | 537.64 |
| 289042-12-2 | |
6-[(1E)-2-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰)氨基]-5-嘧啶]乙烯基]-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯 |
C29H40FN3O6S | 577.71 |
| 885477-83-8 | |
[4-(4-氟苯基)-6-异丙基-2-(N-甲基-N-甲磺酰胺基)-5-嘧啶基]三苯基溴化膦 |
C34H34FN3O2PS.Br | 678.604 |
| 289042-10-0 | |
N-[5-(二苯基膦酰甲基)-4-(4-氟苯基)-6-异丙基嘧啶-2-基]-N-甲基甲磺酰胺 |
C28H29FN3O3PS | 537.59 |
| 147118-36-3 | |
4-(4-氟苯基)-6-异丙基-2-[(N-甲基-N- 甲磺酰胺基)]-嘧啶-5-甲醇 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl)amino]pyrimidine-5-yl-methanol |
C16H20FN3O3S | 353.41 |
| 799842-07-2 | |
5-(溴甲基)-4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰)氨基]嘧啶 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine |
C16H19BrFN3O2S | 416.31 |
| 289042-11-1 | |
4-(4-氟苯基)-6-异丙基-2-[(N-甲基-N-甲磺酰胺基)]-嘧啶-5-甲酸甲酯 |
C17H20FN3O4S | 381.42 |
| 147098-18-8 | |
瑞舒伐他汀钠 Rosuvastatin sodium |
C44H54CaF2N6O12S2 | 503.52 |
| 147118-40-9 | |
瑞舒伐他汀甲酯 Rosuvastatin methyl ester |
C23H30FN3O6S | 495.57 |
| 147118-39-6 | |
瑞舒伐他汀钙J9 |
C23H28FN3O6S | 493.55 |
| 126-14-7 | |
蔗糖八乙酸酯 Sucrose octaacetate |
C28H38O19 | 678.59 |
| 147118-38-5 | |
瑞舒伐他汀钙中间体J8 |
C29H42FN3O6SSi | 607.81 |
| 147118-35-2 | |
(3R)-叔丁基二甲硅氧基-5-氧代-6-三苯基膦烯己酸甲酯 Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidenehexanoate |
C31H39O4PSi | 534.7 |
| 158275-79-7 | |
1-乙氧羰基-5-甲基-(3R)-叔丁基二甲硅氧基戊二酸酯 1-Ethoxycarbonyl-5-methyl-(3R)-3-tert-butyl-dimethylsilyloxypentanedioate |
C15H28O7Si | 348.46 |
| 109744-49-2 | |
(3R)-3-叔丁基二甲基硅氧基戊二酸单甲酯 (3R)-3-(tert-Butyldimethylsilyl)oxypentanedioate-1-methyl monoester |
C12H24O5Si | 276.4 |
| 91424-40-7 | |
3-叔丁基二甲硅氧基戊二酸酐 3-(tert-Butyldimethylsilyloxy)glutaric anhydride |
C11H20O4Si | 244.36 |
